AVIR / Atea Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Atea Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US04683R1068

Deler fremragende 79,672,083 shares
Insideraktier21.581.649 shares
Insider ejerskab27,09 %
Total Insiders25
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
5112 out of 10945

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
5141 out of 10814

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Atea Pharmaceuticals, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Adams Jerome M. Director - [D] 62.750 62.750
Franklin M Berger Director - [D] 506.497 506.497
Cormorant Private Healthcare Fund I, Lp 10% Owner - [10%] 6.411.355 6.411.355
Bihua Chen Director, 10% Owner - [D] [10%] 6.411.355 6.411.355
Isaac Cheng 80.000
Chu Chung K. 10% Owner - [10%] 1.176.862 1.176.862
Andrea Corcoran See Remarks - [O] 823.576 823.576
Cormorant Asset Management, LLC - 6.411.355 6.411.355
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Cormorant Global Healthcare Master Fund, LP 10% Owner - [10%] 6.411.355 6.411.355
Cormorant Private Healthcare Fund II, LP 10% Owner - [10%] 6.411.355 6.411.355
Barbara Gayle Duncan Director - [D] 62.750 62.750
Wayne Foster EVP, Chief Accounting Officer - [O] 79.329 79.329
Hack Andrew A. F. Director - [D] 5.615.659 5.615.659
Janet MJ Hammond Chief Development Officer - [O] 127.665 127.665
Maria Arantxa Horga Chief Medical Officer - [O] 96.086 96.086
JPM Partners LLC 10% Owner - [10%] 5.175.000 5.175.000
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Arthur S Kirsch Director - [D] 10.000 10.000
Bruno Lucidi Director - [D] 112.750 112.750
Murphy Polly A. Director - [D] 86.045 86.045
Bruce Polsky Director - [D] 95.206 95.206
Rock Springs Capital LLC 10% Owner - [10%] 289.695 289.695
Rock Springs Capital Management LP 10% Owner - [10%] 289.695 289.695
Rock Springs Capital Master Fund LP 10% Owner - [10%] 289.695 289.695
Jean-Pierre Sommadossi President, CEO, and Chairman, Director - [D] [O] 767.830 767.830
John Vavricka Chief Commercial Officer - [O] 82.594 82.594

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AVIR / Atea Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2025-01-16 BERGER FRANKLIN M 10.000 3,3614 10.000 3,3614 33.614 190 3.9000 5.386 16,02
2025-01-15 BERGER FRANKLIN M 15.000 3,1923 15.000 3,1923 47.884
2021-12-20 Murphy Polly A. 12.000 8,5663 12.000 8,5663 102.796
2020-11-03 Hack Andrew A. F. 250.000 24,0000 250.000 24,0000 6.000.000
2020-11-03 BERGER FRANKLIN M 41.666 24,0000 41.666 24,0000 999.984
2020-11-03 Rock Springs Capital Management LP 7.292 24,0000 7.292 24,0000 175.008
2020-11-03 Rock Springs Capital Management LP 242.708 24,0000 242.708 24,0000 5.824.992

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AVIR / Atea Pharmaceuticals, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AVIR / Atea Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2024-12-10 BERGER FRANKLIN M 359.606 2,8461 359.606 2,8461 1.023.475 155 2.5500 -106.479 -10,40
2024-09-19 Sommadossi Jean-Pierre 1.841 4,0019 1.841 4,0019 7.367
2024-09-18 Sommadossi Jean-Pierre 22.187 4,0325 22.187 4,0325 89.469
2024-09-17 Sommadossi Jean-Pierre 33.941 4,0458 33.941 4,0458 137.318
2024-06-20 Polsky Bruce 17.544 3,4852 17.544 3,4852 61.144
2024-06-05 Sommadossi Jean-Pierre 1.006 4,0000 1.006 4,0000 4.024
2022-11-14 BERGER FRANKLIN M 16.166 5,1560 16.166 5,1560 83.352
2022-11-11 BERGER FRANKLIN M 25.500 5,1503 25.500 5,1503 131.333

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AVIR / Atea Pharmaceuticals, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-03-13 2026-03-11 4 Corcoran Andrea AVIR Common Stock M - Exercise D 1,2400 60.000 74 823.576
2026-02-03 2026-01-31 4 Horga Maria Arantxa AVIR Common Stock F - Taxes D 4,2400 -16.073 -68 96.086
2026-02-03 2026-01-31 4 Horga Maria Arantxa AVIR Common Stock M - Exercise D 51.283 112.159
2026-02-03 2026-01-31 4 Hammond Janet MJ AVIR Common Stock F - Taxes D 4,2400 -14.136 -60 127.665
2026-02-03 2026-01-31 4 Hammond Janet MJ AVIR Common Stock M - Exercise D 58.050 141.801
2026-02-03 2026-01-31 4 Vavricka John AVIR Common Stock F - Taxes D 4,2400 -11.570 -49 82.594
2026-02-03 2026-01-31 4 Vavricka John AVIR Common Stock M - Exercise D 42.083 94.164
2026-02-03 2026-02-03 4 Sommadossi Jean-Pierre AVIR Common Stock M - Exercise D 1,2400 300.000 372 767.830
2026-02-03 2026-01-31 4 Sommadossi Jean-Pierre AVIR Common Stock F - Taxes D 4,2400 -106.093 -450 467.830
2026-02-03 2026-01-31 4 Sommadossi Jean-Pierre AVIR Common Stock M - Exercise D 272.983 573.923
2026-02-03 2026-01-31 4 Corcoran Andrea AVIR Common Stock F - Taxes D 4,2400 -16.104 -68 763.576
2026-02-03 2026-01-31 4 Corcoran Andrea AVIR Common Stock M - Exercise D 54.866 779.680
2026-02-03 2026-01-31 4 Foster Wayne AVIR Common Stock F - Taxes D 4,2400 -12.132 -51 79.329
2026-02-03 2026-01-31 4 Foster Wayne AVIR Common Stock M - Exercise D 41.333 91.461
2025-06-24 2025-06-20 4 Lucidi Bruno AVIR Common Stock M - Exercise D 29.600 112.750
2025-06-24 2025-06-20 4 Adams Jerome M. AVIR Common Stock M - Exercise D 29.600 62.750
2025-06-24 2025-06-20 4 Polsky Bruce AVIR Common Stock M - Exercise D 29.600 95.206
2025-06-24 2025-06-20 4 BERGER FRANKLIN M AVIR Common Stock M - Exercise D 29.600 506.497
2025-06-24 2025-06-20 4 Duncan Barbara Gayle AVIR Common Stock M - Exercise D 29.600 62.750
2025-06-24 2025-06-20 4 Murphy Polly A. AVIR Common Stock M - Exercise D 29.600 86.045
2025-02-24 3 Kirsch Arthur S By trust AVIR Common Stock I 10.000
2025-02-24 3 Kirsch Arthur S AVIR Common Stock D 35.710
2025-02-04 2025-01-31 4 Foster Wayne AVIR Common Stock F - Taxes D 3,0600 -12.062 -37 50.128
2025-02-04 2025-01-31 4 Foster Wayne AVIR Common Stock A - Award D 8.000 62.190
2025-02-04 2025-01-31 4 Foster Wayne AVIR Common Stock M - Exercise D 33.333 54.190
2025-02-04 2025-01-31 4 Sommadossi Jean-Pierre AVIR Common Stock F - Taxes D 3,0600 -88.601 -271 300.940
2025-02-04 2025-01-31 4 Sommadossi Jean-Pierre AVIR Common Stock A - Award D 99.517 389.541
2025-02-04 2025-01-31 4 Sommadossi Jean-Pierre AVIR Common Stock M - Exercise D 173.467 290.024
2025-02-04 2025-01-31 4 Horga Maria Arantxa AVIR Common Stock F - Taxes D 3,0600 -16.071 -49 60.876
2025-02-04 2025-01-31 4 Horga Maria Arantxa AVIR Common Stock A - Award D 9.750 76.947
2025-02-04 2025-01-31 4 Horga Maria Arantxa AVIR Common Stock M - Exercise D 41.533 67.197
2025-02-04 2025-01-31 4 Corcoran Andrea AVIR Common Stock F - Taxes D 3,0600 -16.102 -49 717.307
2025-02-04 2025-01-31 4 Corcoran Andrea AVIR Common Stock A - Award D 10.500 733.409
2025-02-04 2025-01-31 4 Corcoran Andrea AVIR Common Stock M - Exercise D 44.367 722.909
2025-02-04 2025-01-31 4 Hammond Janet MJ AVIR Common Stock F - Taxes D 3,0600 -14.134 -43 81.388
2025-02-04 2025-01-31 4 Hammond Janet MJ AVIR Common Stock A - Award D 11.250 95.522
2025-02-04 2025-01-31 4 Hammond Janet MJ AVIR Common Stock M - Exercise D 46.800 84.272
2025-02-04 2025-01-31 4 Vavricka John AVIR Common Stock F - Taxes D 3,0600 -11.517 -35 52.081
2025-02-04 2025-01-31 4 Vavricka John AVIR Common Stock A - Award D 8.750 63.598
2025-02-04 2025-01-31 4 Vavricka John AVIR Common Stock M - Exercise D 33.333 54.848
2025-01-17 2025-01-16 4/A BERGER FRANKLIN M AVIR Common Stock P - Purchase D 3,3614 10.000 34 476.897
2025-01-17 2025-01-15 4/A BERGER FRANKLIN M AVIR Common Stock P - Purchase D 3,1923 15.000 48 466.897
2025-01-17 2025-01-16 4 BERGER FRANKLIN M AVIR Common Stock P - Purchase D 3,3614 -10.000 -34 476.897
2025-01-17 2025-01-15 4 BERGER FRANKLIN M AVIR Common Stock P - Purchase D 3,1923 -15.000 -48 466.897
2024-12-12 2024-12-10 4 BERGER FRANKLIN M AVIR Common Stock S - Sale D 2,8461 -359.606 -1.023 451.897
2024-09-19 2024-09-19 4 Sommadossi Jean-Pierre Held by JPM Partners LLC AVIR Common Stock S - Sale I 4,0019 -1.841 -7 5.866.025
2024-09-19 2024-09-18 4 Sommadossi Jean-Pierre Held by JPM Partners LLC AVIR Common Stock S - Sale I 4,0325 -22.187 -89 5.867.866
2024-09-19 2024-09-17 4 Sommadossi Jean-Pierre Held by JPM Partners LLC AVIR Common Stock S - Sale I 4,0458 -33.941 -137 5.890.053
2024-06-21 2024-06-20 4 Polsky Bruce AVIR Common Stock S - Sale D 3,4852 -17.544 -61 65.606
2024-06-18 2024-06-16 4 Duncan Barbara Gayle AVIR Common Stock M - Exercise D 33.150 33.150
2024-06-18 2024-06-16 4 BERGER FRANKLIN M AVIR Common Stock M - Exercise D 33.150 811.503
2024-06-18 2024-06-16 4 Adams Jerome M. AVIR Common Stock M - Exercise D 33.150 33.150
2024-06-18 2024-06-16 4 Polsky Bruce AVIR Common Stock M - Exercise D 33.150 83.150
2024-06-18 2024-06-16 4 Lucidi Bruno AVIR Common Stock M - Exercise D 33.150 83.150
2024-06-18 2024-06-16 4 Murphy Polly A. AVIR Common Stock M - Exercise D 33.150 56.445
2024-06-07 2024-06-05 4 Sommadossi Jean-Pierre Held by JPM Partners LLC AVIR Common Stock S - Sale I 4,0000 -1.006 -4 5.923.994
2024-02-02 2024-02-01 4 Corcoran Andrea AVIR Common Stock S - Sale D 3,8449 -15.843 -61 670.208
2024-02-02 2024-01-31 4 Corcoran Andrea AVIR Common Stock M - Exercise D 44.367 686.051
2024-02-02 2024-02-01 4 Sommadossi Jean-Pierre AVIR Common Stock S - Sale D 3,8450 -56.910 -219 116.557
2024-02-02 2024-01-31 4 Sommadossi Jean-Pierre AVIR Common Stock M - Exercise D 173.467 173.467
2024-02-02 2024-02-01 4 Horga Maria Arantxa AVIR Common Stock S - Sale D 3,8414 -15.870 -61 25.664
2024-02-02 2024-01-31 4 Horga Maria Arantxa AVIR Common Stock M - Exercise D 41.534 41.534
2024-02-02 2024-02-01 4 Vavricka John AVIR Common Stock S - Sale D 3,8430 -11.819 -45 21.515
2024-02-02 2024-01-31 4 Vavricka John AVIR Common Stock M - Exercise D 33.334 33.334
2024-02-02 2024-02-01 4 Foster Wayne AVIR Common Stock S - Sale D 3,8394 -12.477 -48 20.857
2024-02-02 2024-01-31 4 Foster Wayne AVIR Common Stock M - Exercise D 33.334 33.334
2024-02-02 2024-02-01 4 Hammond Janet MJ AVIR Common Stock S - Sale D 3,8430 -14.029 -54 35.362
2024-02-02 2024-01-31 4 Hammond Janet MJ AVIR Common Stock M - Exercise D 46.800 49.391
2022-11-15 2022-11-14 4 BERGER FRANKLIN M AVIR Common Stock S - Sale D 5,1560 -16.166 -83 778.353
2022-11-15 2022-11-11 4 BERGER FRANKLIN M AVIR Common Stock S - Sale D 5,1503 -25.500 -131 794.519
2022-02-02 2022-01-31 4 Sommadossi Jean-Pierre AVIR Stock Option (Right to Buy) A - Award D 7,14 378.033 378.033
2022-02-02 2022-01-31 4 Hammond Janet MJ AVIR Stock Option (Right to Buy) A - Award D 7,14 190.000 190.000
2022-02-02 2022-01-31 4 Horga Maria Arantxa AVIR Stock Option (Right to Buy) A - Award D 7,14 170.000 170.000
2022-02-02 2022-01-31 4 Corcoran Andrea AVIR Stock Option (Right to Buy) A - Award D 7,14 181.000 181.000
2022-02-02 2022-01-31 4 Vavricka John AVIR Stock Option (Right to Buy) A - Award D 7,14 135.000 135.000
2022-02-02 2022-01-31 4 Foster Wayne AVIR Stock Option (Right to Buy) A - Award D 7,14 120.000 120.000
2021-12-21 2021-12-20 4 Murphy Polly A. AVIR Common Stock P - Purchase D 8,5663 12.000 103 23.295
2021-06-21 2021-06-18 4 Polsky Bruce AVIR Stock Option (Right to Buy) A - Award D 23,39 34.025 34.025
2021-06-21 2021-06-18 4 BERGER FRANKLIN M AVIR Stock Option (Right to Buy) A - Award D 23,39 34.025 34.025
2021-06-21 2021-06-18 4 Duncan Barbara Gayle AVIR Stock Option (Right to Buy) A - Award D 23,39 34.025 34.025
2021-06-21 2021-06-18 4 Lucidi Bruno AVIR Stock Option (Right to Buy) A - Award D 23,39 34.025 34.025
2021-06-21 2021-06-18 4 Murphy Polly A. AVIR Stock Option (Right to Buy) A - Award D 23,39 34.025 34.025
2021-05-20 2021-05-18 4 Adams Jerome M. AVIR Stock Option (Right to Buy) A - Award D 23,43 56.670 56.670
2021-02-01 2021-01-29 4 Sommadossi Jean-Pierre AVIR Stock Option (Right to Buy) A - Award D 73,00 640.000 640.000
2021-02-01 2021-01-29 4 Hammond Janet MJ AVIR Stock Option (Right to Buy) A - Award D 73,00 160.050 160.050
2021-02-01 2021-01-29 4 Horga Maria Arantxa AVIR Stock Option (Right to Buy) A - Award D 73,00 145.500 145.500
2021-02-01 2021-01-29 4 Vavricka John AVIR Stock Option (Right to Buy) A - Award D 73,00 117.300 117.300
2021-02-01 2021-01-29 4 Corcoran Andrea AVIR Stock Option (Right to Buy) A - Award D 73,00 148.850 148.850
2021-02-01 2021-01-29 4 Foster Wayne AVIR Stock Option (Right to Buy) A - Award D 73,00 71.750 71.750
2020-11-05 2020-11-03 4 Cormorant Asset Management, LLC See Footnotes AVIR Series D-1 Convertible Preferred Stock C - Conversion I -417.360 0
2020-11-05 2020-11-03 4 Cormorant Asset Management, LLC See Footnotes AVIR Series D Convertible Preferred Stock C - Conversion I -712.250 0
2020-11-05 2020-11-03 4 Cormorant Asset Management, LLC See Footnotes AVIR Series C Convertible Preferred Stock C - Conversion I -2.631.580 0
2020-11-05 2020-11-03 4 Cormorant Asset Management, LLC See Footnotes AVIR Series B Convertible Preferred Stock C - Conversion I -1.650.165 0
2020-11-05 2020-11-03 4 Cormorant Asset Management, LLC See Footnotes AVIR Series A Convertible Preferred Stock C - Conversion I -1.000.000 0
2020-11-05 2020-11-03 4 Cormorant Asset Management, LLC See Footnotes AVIR Common Stock C - Conversion I 6.411.355 6.411.355
2020-11-04 2020-11-03 4 Rock Springs Capital Management LP AVIR Series D-1 Convertible Preferred Stock C - Conversion I -104.340 0
2020-11-04 2020-11-03 4 Rock Springs Capital Management LP AVIR Series D Convertible Preferred Stock C - Conversion I -178.063 0
2020-11-04 2020-11-03 4 Rock Springs Capital Management LP AVIR Series D-1 Convertible Preferred Stock C - Conversion I -521.703 0
2020-11-04 2020-11-03 4 Rock Springs Capital Management LP AVIR Series D Convertible Preferred Stock C - Conversion I -890.313 0
2020-11-04 2020-11-03 4 Rock Springs Capital Management LP AVIR Common Stock P - Purchase I 24,0000 7.292 175 289.695
2020-11-04 2020-11-03 4 Rock Springs Capital Management LP AVIR Common Stock P - Purchase I 24,0000 242.708 5.825 1.654.724
2020-11-04 2020-11-03 4 Rock Springs Capital Management LP AVIR Common Stock C - Conversion I 282.403 282.403
2020-11-04 2020-11-03 4 Rock Springs Capital Management LP AVIR Common Stock C - Conversion I 1.412.016 1.412.016
2020-11-03 2020-11-03 4 Hack Andrew A. F. See Footnotes AVIR Series D-1 Convertible Preferred Stock C - Conversion I -1.982.469 0
2020-11-03 2020-11-03 4 Hack Andrew A. F. See Footnotes AVIR Series D Convertible Preferred Stock C - Conversion I -3.383.190 0
2020-11-03 2020-11-03 4 Hack Andrew A. F. See Footnotes AVIR Common Stock P - Purchase I 24,0000 250.000 6.000 5.615.659
2020-11-03 2020-11-03 4 Hack Andrew A. F. See Footnotes AVIR Common Stock C - Conversion I 5.365.659 5.365.659
2020-11-03 2020-11-03 4 Corcoran Andrea AVIR Series B Convertible Preferred Stock C - Conversion D -33.004 0
2020-11-03 2020-11-03 4 Corcoran Andrea AVIR Series A Convertible Preferred Stock C - Conversion D -100.000 0
2020-11-03 2020-11-03 4 Corcoran Andrea AVIR Common Stock C - Conversion D 133.004 633.004
2020-11-03 2020-11-03 4 Sommadossi Jean-Pierre Held by JPM Partners LLC AVIR Series A Convertible Preferred Stock C - Conversion I -750.000 0
2020-11-03 2020-11-03 4 Sommadossi Jean-Pierre Held by JPM Partners LLC AVIR Common Stock C - Conversion I 750.000 5.925.000
2020-11-03 2020-11-03 4 BERGER FRANKLIN M AVIR Series D-1 Convertible Preferred Stock C - Conversion D -35.474 0
2020-11-03 2020-11-03 4 BERGER FRANKLIN M AVIR Series D Convertible Preferred Stock C - Conversion D -60.540 0
2020-11-03 2020-11-03 4 BERGER FRANKLIN M AVIR Series C Convertible Preferred Stock C - Conversion D -131.578 0
2020-11-03 2020-11-03 4 BERGER FRANKLIN M AVIR Series B Convertible Preferred Stock C - Conversion D -132.014 0
2020-11-03 2020-11-03 4 BERGER FRANKLIN M AVIR Series A Convertible Preferred Stock C - Conversion D -400.000 0
2020-11-03 2020-11-03 4 BERGER FRANKLIN M AVIR Common Stock P - Purchase D 24,0000 41.666 1.000 820.019
2020-11-03 2020-11-03 4 BERGER FRANKLIN M AVIR Common Stock C - Conversion D 759.606 778.353
2020-11-03 2020-11-03 4 Murphy Polly A. Held by the Marc & Polly Murphy Revocable Family Trust dated March 13, 2002 AVIR Series D-1 Convertible Preferred Stock C - Conversion I -4.173 0
2020-11-03 2020-11-03 4 Murphy Polly A. Held by the Marc & Polly Murphy Revocable Family Trust dated March 13, 2002 AVIR Series D Convertible Preferred Stock C - Conversion I -7.122 0
2020-11-03 2020-11-03 4 Murphy Polly A. Held by the Marc & Polly Murphy Revocable Family Trust dated March 13, 2002 AVIR Common Stock C - Conversion I 11.295 11.295
2020-11-03 2020-11-03 4 Chu Chung K. AVIR Series C Convertible Preferred Stock C - Conversion D -43.859 0
2020-11-03 2020-11-03 4 Chu Chung K. AVIR Series B Convertible Preferred Stock C - Conversion D -33.003 0
2020-11-03 2020-11-03 4 Chu Chung K. AVIR Series A Convertible Preferred Stock C - Conversion D -100.000 0
2020-11-03 2020-11-03 4 Chu Chung K. AVIR Common Stock C - Conversion D 176.862 1.176.862
2020-11-03 2020-11-03 4 Vavricka John Held by John Vavricka as the Trustee of the John F. Vavricka Deed of Trust AVIR Series B Convertible Preferred Stock C - Conversion I -82.508 0
2020-11-03 2020-11-03 4 Vavricka John Held by John Vavricka as the Trustee of the John F. Vavricka Deed of Trust AVIR Common Stock C - Conversion I 82.508 82.508
2020-10-30 2020-10-29 4 BERGER FRANKLIN M AVIR Stock Option (Right to Buy) A - Award D 24,00 80.000 80.000
2020-10-30 2020-10-29 4 Duncan Barbara Gayle AVIR Stock Option (Right to Buy) A - Award D 24,00 80.000 80.000
2020-10-30 2020-10-29 4 Cheng Isaac AVIR Stock Option (Right to Buy) A - Award D 24,00 80.000 80.000
2020-10-30 2020-10-29 4 Foster Wayne AVIR Stock Option (Right to Buy) A - Award D 24,00 40.000 40.000
2020-10-30 2020-10-29 4 Polsky Bruce AVIR Stock Option (Right to Buy) A - Award D 24,00 80.000 80.000
2020-10-30 2020-10-29 4 Lucidi Bruno AVIR Stock Option (Right to Buy) A - Award D 24,00 80.000 80.000
2020-10-30 2020-10-29 4 Hack Andrew A. F. AVIR Stock Option (Right to Buy) A - Award D 24,00 80.000 80.000
2020-10-29 3 Lucidi Bruno AVIR Common Stock D 50.000
2020-10-29 3 Chu Chung K. AVIR Common Stock D 1.000.000
2020-10-29 3 Corcoran Andrea AVIR Common Stock D 500.000
2020-10-29 3 JPM Partners LLC Held by JPM Partners LLC AVIR Common Stock I 5.175.000
2020-10-29 3 Polsky Bruce AVIR Common Stock D 50.000
2020-10-29 3 BERGER FRANKLIN M AVIR Common Stock D 18.747
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista